Martha Brumfield, Ph.D.

President and CEO
Critical Path Institute (C-Path)

Martha A. Brumfield, PhD, is President and Chief Executive Officer of Critical Path Institute, an Arizona based non-profit (501(c) 3).  In this role, Brumfield leads the institute in its mission to catalyze the development of new tools to advance medical product innovation and regulatory science which is accomplished by leading teams that share data, knowledge and expertise resulting in sound, consensus based science.  Brumfield assumes the role of CEO after most recently serving as Critical Path Institute's director of International & Regulatory Programs. In that position, she helped guide international program development and provided regulatory expertise to consortia.

She also has her own consulting practice (Martha A. Brumfield LLC) focusing on concordance in global regulatory initiatives and regulatory science qualification programs. Other areas of focus in her practice include excellence in clinical trial conduct and pharmacovigilance, facilitation of scientific consortia and programs supporting patient access to medicines.

Brumfield brings 20 years of experience from Pfizer, Inc., most recently, as senior vice president of worldwide regulatory affairs and quality assurance. There, she led a global team that supported lifecycle pharmaceutical research, development and commercialization through creation and implementation of regulatory strategies and quality assurance oversight. Brumfield also played a key role in managing the broader company relationships with global regulators, trade associations, academics and others on regulatory policy issues. She served on corporate governance initiatives including the planning and implementation of mergers and acquisitions and led her departments through these periods of significant change.

She serves on the Board of Directors for the Regulatory Affairs Professional Society, participates in an advisory capacity to the Harvard Global Health Institute's Multi-Regional Clinical Trial Center in developing a curriculum for potential Data and Safety Monitoring Board candidates from developing countries. She is also active with global nonprofits, including the Regulatory Harmonization Institute and GlobalMD, where she delivers educational workshops on regulatory and clinical trial topics in Asia. She has served on and contributed to the International Office of Medicine consensus committees, which were commissioned by U.S. FDA focusing on global regulatory systems.

Brumfield earned a B.S. and an M.S. in chemistry from Virginia Commonwealth University, a Ph.D. in organic chemistry from the University of Maryland, and served as a post-doctoral fellow at the Rockefeller University.